Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber
- PMID: 24724735
- DOI: 10.3109/09273948.2014.902074
Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber
Abstract
Purpose: To report two cases of spontaneous Retisert implant dissociation with dislocation of the medication reservoir into the anterior chamber.
Design and methods: Case reports.
Results: Two patients with chronic, noninfectious uveitis following Retisert implantation between 6 and 7 years prior presented with a complaint of a "white spot" in their right eyes. Both patients had previous pars plana vitrectomies. Anterior segment examination revealed a dislocated medication reservoir of the Retisert implant in the inferior portion of anterior chamber with associated reservoir-corneal endothelial touch and stromal edema. The reservoirs were subsequently retrieved via a pars plana approach and removed from the anterior chamber through a corneal incision.
Conclusions: Spontaneous dissociation of the Retisert implant with dislocation of the medication reservoir into the anterior chamber can be a late complication of Retisert implantation. Eye care professionals and patients should be aware of this complication, particularly with long-term intraocular retention of this device.
Keywords: Anterior chamber; Retisert; dislocation; dissociation; fluocinolone acetonide; implant; separation; spontaneous; uveitis.
Similar articles
-
Spontaneous dissociation and dislocation of Retisert pellet.Ocul Immunol Inflamm. 2013;21(1):87-9. doi: 10.3109/09273948.2012.736585. Ocul Immunol Inflamm. 2013. PMID: 23590151
-
Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert).Ocul Immunol Inflamm. 2013;21(1):77-8. doi: 10.3109/09273948.2012.736588. Ocul Immunol Inflamm. 2013. PMID: 23323586
-
Spontaneous dislocation of a fluocinolone acetonide implant (Retisert) into the anterior chamber and its successful extraction in sympathetic ophthalmia.Retin Cases Brief Rep. 2015 Spring;9(2):142-4. doi: 10.1097/ICB.0000000000000119. Retin Cases Brief Rep. 2015. PMID: 25411930
-
Retisert: is the new advance in treatment of uveitis a good one?Ann Pharmacother. 2007 Mar;41(3):449-54. doi: 10.1345/aph.1H540. Epub 2007 Mar 6. Ann Pharmacother. 2007. PMID: 17341531 Review.
-
Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.Drugs R D. 2005;6(2):116-9. doi: 10.2165/00126839-200506020-00007. Drugs R D. 2005. PMID: 15777105 Review.
Cited by
-
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.J Ophthalmic Inflamm Infect. 2019 Jan 29;9(1):3. doi: 10.1186/s12348-019-0168-9. J Ophthalmic Inflamm Infect. 2019. PMID: 30694420 Free PMC article.
-
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases.Biomed Microdevices. 2019 May 18;21(2):47. doi: 10.1007/s10544-019-0389-6. Biomed Microdevices. 2019. PMID: 31104136 Free PMC article. Review.
-
Dexamethasone Implant Migration through an Iris Coloboma.Case Rep Ophthalmol. 2020 Feb 5;11(1):73-78. doi: 10.1159/000505638. eCollection 2020 Jan-Apr. Case Rep Ophthalmol. 2020. PMID: 32110233 Free PMC article.
-
Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design.Drug Deliv Transl Res. 2021 Oct;11(5):1903-1923. doi: 10.1007/s13346-020-00879-1. Epub 2021 Jan 16. Drug Deliv Transl Res. 2021. PMID: 33454927 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous